{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:30:40Z","timestamp":1792693840906,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ijporlonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pediatric Otorhinolaryngology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ijporl.2015.01.003","type":"journal-article","created":{"date-parts":[[2015,1,15]],"date-time":"2015-01-15T17:47:46Z","timestamp":1421344066000},"page":"296-300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Do orally administered antibiotics reach concentrations in the middle ear sufficient to eradicate planktonic and biofilm bacteria? A review"],"prefix":"10.1016","volume":"79","author":[{"given":"Katherine","family":"Belfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Bayston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Birchall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matija","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijporl.2015.01.003_bib0245","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0140-6736(04)15495-0","article-title":"Otitis media","volume":"363","author":"Rovers","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijporl.2015.01.003_bib0250","doi-asserted-by":"crossref","first-page":"e964","DOI":"10.1542\/peds.2012-3488","article-title":"The diagnosis and management of acute otitis media","volume":"131","author":"Lieberthal","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijporl.2015.01.003_bib0255","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1365-2273.2000.00350.x","article-title":"The aetiology of otitis media with effusion: a review","volume":"25","author":"Kubba","year":"2000","journal-title":"Clin. Otolaryngol. Allied Sci."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0260","unstructured":"Health and Social Care Information Centre, Hospital Episode Statistics\u2212Admitted Patient Care-England-2010\u22122011: Main operations, 3 characters list. \u3008www.hscic.gov.uk\/hes\u3009 (Accessed June, 2014)."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0265","series-title":"Clinical Otology","first-page":"223","article-title":"Otitis media","author":"Sautter","year":"2007"},{"key":"10.1016\/j.ijporl.2015.01.003_bib0270","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ijporl.2005.10.004","article-title":"Bacterial etiology of acute otitis media and clinical efficacy of amoxicillin\u2013clavulanate versus azithromycin","volume":"70","author":"Guven","year":"2006","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0275","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0165-5876(02)00360-9","article-title":"Etiology of acute otitis media in childhood and evaluation of two different protocols of antibiotic therapy: 10 days cefaclor vs 3 days azithromycin","volume":"67","author":"O\u011fuz","year":"2003","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0280","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.otorri.2012.06.005","article-title":"Acute otitis media: prevalence of ear pathogens in patients at a public hospital","volume":"64","author":"Sommerfleck","year":"2013","journal-title":"Acta Otorhinolaryngol. Esp."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0285","first-page":"94","article-title":"Acute otitis media and respiratory virus infections","volume":"8","author":"Ruuskanen","year":"1989","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0290","first-page":"15","article-title":"Update on otitis media-prevention and treatment","volume":"7","author":"Qureishi","year":"2014","journal-title":"Infect. Drug Resis."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0295","series-title":"Surgical Management of Otitis Media with Effusion in Children","author":"NICE (National Institute for Health and Clinical Excellence)","year":"2008"},{"key":"10.1016\/j.ijporl.2015.01.003_bib0300","first-page":"CD009163","article-title":"Antibiotics for otitis media with effusion in children","volume":"12","author":"van Zon","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0305","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/coa.12069","article-title":"Antibiotics for otitis media with effusion in children","volume":"38","author":"Daniel","year":"2013","journal-title":"Clin. Otolaryngol."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0310","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.ijporl.2012.06.013","article-title":"Bacterial involvement in otitis media with effusion","volume":"76","author":"Daniel","year":"2012","journal-title":"Int. J. Pediatr. Otorhinolarnygol."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0315","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/jama.296.2.202","article-title":"Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media","volume":"296","author":"Hall-Stoodley","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ijporl.2015.01.003_bib0320","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrmicro2415","article-title":"The biofilm matrix","volume":"8","author":"Flemming","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0325","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1001\/archotol.2013.238","article-title":"Biofilm eradication with biodegradable modified-release antibiotic pellets","volume":"138","author":"Daniel","year":"2012","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0330","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1128\/CMR.15.2.167-193.2002","article-title":"Biofilms: survival mechanisms of clinically relevant microorganisms","volume":"15","author":"Donlan","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0335","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.mcna.2006.07.009","article-title":"Oral antibiotic therapy of serious systemic infections","volume":"90","author":"Cunha","year":"2006","journal-title":"Med. Clin. North. Am."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0340","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1128\/AAC.44.1.43-50.2000","article-title":"Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children","volume":"44","author":"Dagan","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0345","series-title":"EUCAST SOP 2.1","article-title":"Setting breakpoints for existing antimicrobial agents","author":"European Committee on Antimicrobial Susceptibility Testing","year":"2013"},{"key":"10.1016\/j.ijporl.2015.01.003_bib0350","doi-asserted-by":"crossref","first-page":"E37","DOI":"10.1111\/j.1469-0691.2011.03752.x","article-title":"The role of pharmacokinetics\/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach","volume":"18","author":"Mouton","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"issue":"Suppl 1","key":"10.1016\/j.ijporl.2015.01.003_bib0355","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jac\/48.suppl_1.17","article-title":"Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests","volume":"48","author":"MacGowan","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0360","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/03009734.2014.904457","article-title":"Selection of antibiotic resistance at very low antibiotic concentrations","volume":"119","author":"Sandegren","year":"2014","journal-title":"Ups. J. Med. Sci."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0365","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2203\/dose-response.13-021.Kaplan","article-title":"Induction of MRSA biofilm by low-dose \u03b2-lactam antibiotics: specificity, prevalence and dose-response effects","volume":"12","author":"Ng","year":"2013","journal-title":"Dose Response"},{"key":"10.1016\/j.ijporl.2015.01.003_bib0370","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/infdis\/145.6.815","article-title":"Penetration of amoxicillin, cefaclor, erythromycin\u2013sulfisoxazole, and trimethoprim\u2013sulfamethoxazole into the middle ear fluid of patients with chronic serous otitis media","volume":"145","author":"Krause","year":"1982","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0375","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/BF01975162","article-title":"Serum levels of ciprofloxacin after single oral doses in patients with septicemia","volume":"8","author":"D\u2019Espine","year":"1989","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.ijporl.2015.01.003_bib0380","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000239309","article-title":"Study of the distribution of oral ciprofloxacin into the mucosa of the middle ear and the cortical bone of the mastoid process","volume":"40","author":"Massias","year":"1994","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijporl.2015.01.003_bib0385","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1183\/09031936.94.07071275","article-title":"The levels of clarithromycin and its 14-hydroxy metabolite in the lung","volume":"7","author":"Honeybourne","year":"1994","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0390","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00006454-199701000-00009","article-title":"Penetration of clarithromycin into middle ear fluid of children with acute otitis media","volume":"16","author":"Gan","year":"1997","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0395","first-page":"987","article-title":"Lincomycin and clindamycin","volume":"vol. 1","author":"Klutymans","year":"2010"},{"key":"10.1016\/j.ijporl.2015.01.003_bib0400","first-page":"187","article-title":"Amoxicillin\u2013clavulanic acid (co-amoxiclav)","volume":"vol. 1","author":"Gordon","year":"2010"},{"issue":"Suppl. A","key":"10.1016\/j.ijporl.2015.01.003_bib0405","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jac\/25.suppl_A.73","article-title":"The pharmacokinetics of azithromycin in human serum and tissues","volume":"25","author":"Foulds","year":"1990","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0410","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0140-6736(01)05321-1","article-title":"Antibiotic resistance of bacteria in biofilms","volume":"358","author":"Stewart","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ijporl.2015.01.003_bib0415","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/JCM.37.6.1771-1776.1999","article-title":"The calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms","volume":"37","author":"Ceri","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0420","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s10156-013-0592-y","article-title":"Minimal biofilm eradication concentration of antimicrobial agents against nontypeable Haemophilus influenzae isolated from middle ear fluids of intractable acute otitis media","volume":"19","author":"Takei","year":"2013","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0425","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.diagmicrobio.2012.08.021","article-title":"Antibiotic susceptibility of Moraxella catarrhalis biofilms in continuous flow model","volume":"74","author":"Matejka","year":"2012","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0430","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/jac\/dkn538","article-title":"Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics","volume":"63","author":"Harrison","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0435","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1093\/jac\/dku158","article-title":"Frequent carriage of resistance mechanisms to \u03b2-lactams and biofilm formation in Haemophilus influenzae causing treatment failure in recurrent otitis media in young children","volume":"69","author":"Garc\u00eda-Cobos","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0440","series-title":"Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net)","article-title":"Antimicrobial resistance surveillance in Europe 2011","author":"European Centre for Disease Prevention and Control","year":"2012"},{"key":"10.1016\/j.ijporl.2015.01.003_bib0445","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.peptides.2013.08.008","article-title":"Pharmacokinetics of antimicrobial cationic peptides alone and in combination with antibiotics against methicillin resistant Staphylococcus aureus biofilms","volume":"49","author":"Dosler","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.ijporl.2015.01.003_bib0450","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/jor.22065","article-title":"Evaluation of MBEC\u2122-HTP biofilm model for studies of implant associated infections","volume":"30","author":"Cora\u00e7a-Hub\u00e9r","year":"2012","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0455","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF01977494","article-title":"Pharmokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers","volume":"3","author":"Wingender","year":"1984","journal-title":"Eur. J. Clin. Microbiol."},{"issue":"3 Pt 3","key":"10.1016\/j.ijporl.2015.01.003_bib0460","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/00034894810903S211","article-title":"Pharmacokinetics of cefaclor in chronic middle ear effusions","volume":"90","author":"Lildholdt","year":"1981","journal-title":"Ann. Otol. Rhinol. Laryngol. Suppl."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0465","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/infdis\/133.5.578","article-title":"Summary of a workshop on clindamycin colitis","volume":"133","author":"Keusch","year":"1976","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0470","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.ijporl.2012.09.005","article-title":"Middle ear fluid characteristics in pediatric otitis media with effusion","volume":"76","author":"Dodson","year":"2012","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0475","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1365-2125.1999.00887.x","article-title":"Interpretation of middle ear fluid concentrations of antibiotics: comparison between ceftibuten, cefixime, and azithromycin","volume":"47","author":"Scaglione","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijporl.2015.01.003_bib0480","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4155\/tde.12.130","article-title":"Drug delivery to the ear","volume":"4","author":"Hoskison","year":"2013","journal-title":"Ther. Deliv."}],"container-title":["International Journal of Pediatric Otorhinolaryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165587615000191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165587615000191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T01:26:28Z","timestamp":1598664388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165587615000191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0165587615000191"],"URL":"https:\/\/doi.org\/10.1016\/j.ijporl.2015.01.003","relation":{},"ISSN":["0165-5876"],"issn-type":[{"value":"0165-5876","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do orally administered antibiotics reach concentrations in the middle ear sufficient to eradicate planktonic and biofilm bacteria? A review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pediatric Otorhinolaryngology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijporl.2015.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}